Publications by authors named "M I H Al-Jazairi"
Background: Preventing high heart rates in patients with atrial fibrillation (AF) is a key objective of AF management. Data regarding heart rates in patients with paroxysmal AF (PAF) is lacking. This analysis aimed to provide insight into heart rates during PAF episodes measured with continuous implantable loop monitoring.
View Article and Find Full Text PDFObjective: Atrial fibrillation (AF) often progresses from paroxysmal AF (PAF) to more permanent forms. To improve personalised medicine, we aim to develop a new AF progression risk prediction model in patients with PAF.
Methods: In this interim-analysis of the Reappraisal of AF: Interaction Between HyperCoagulability, Electrical Remodelling, and Vascular Destabilisation in the Progression of AF study, patients with PAF undergoing extensive phenotyping at baseline and continuous rhythm monitoring during follow-up of ≥1 year were analysed.
Introduction: Pulmonary vein isolation (PVI) is an important treatment for atrial fibrillation (AF). However, many patients need more than one procedure to maintain long-term sinus rhythm. Even after two PVIs some may suffer from AF recurrences.
View Article and Find Full Text PDFAims: This study evaluates the efficacy and safety of first-line single-stage hybrid ablation of (long-standing) persistent atrial fibrillation (AF), over a follow-up period of 2 years, and provides additional information on arrhythmia recurrences and electrophysiological findings at repeat ablation.
Methods And Results: This is a prospective cohort study that included 49 patients (65% persistent AF; 35% long-standing persistent AF) who underwent hybrid ablation as first-line ablation treatment (no previous endocardial ablation). Patients were relatively young (57.
Article Synopsis
- The study aimed to evaluate the effectiveness of antiarrhythmic drugs (AADs) in maintaining sinus rhythm for patients with persistent atrial fibrillation (AF) and mild to moderate heart failure (HF).
- In the RACE 3 trial, 245 patients were randomly assigned to receive either targeted therapy, which included additional medications, or conventional therapy, with the primary outcome being sinus rhythm after one year.
- Results showed that nearly 68% of patients treated with AADs were in sinus rhythm after one year, with amiodarone proving to be the most effective drug, and the treatment had no serious adverse effects.